Quarterly report pursuant to Section 13 or 15(d)

Reportable Segments and Revenue - Segment Related Information (Details)

v3.24.1.1.u2
Reportable Segments and Revenue - Segment Related Information (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2024
USD ($)
segment
Mar. 31, 2023
USD ($)
Segment Information    
Number of reportable segments | segment 4  
Revenue $ 37,504 $ 42,264
Share-based compensation 107 293
Depreciation and amortization 3,866 4,129
Wages and benefits 4,496 5,784
Impairment loss 12 188
Interest expense 6,043 4,092
Loan losses   388
Net loss (9,651) (4,866)
Cannabis    
Segment Information    
Revenue 10,389 12,961
Depreciation and amortization 647 794
Wages and benefits 1,852 2,221
Impairment loss 12 48
Interest expense 1,369 1,356
Net loss (1,874) (6,648)
Accessories    
Segment Information    
Revenue 27,115 29,303
Depreciation and amortization 3,219 3,238
Wages and benefits 1,267 1,273
Interest expense 925 642
Net loss (2,581) (2,650)
Corporate    
Segment Information    
Share-based compensation 107 241
Depreciation and amortization   14
Wages and benefits 1,377 2,290
Impairment loss   140
Interest expense 3,749 2,094
Loan losses   388
Net loss (5,194) (3,613)
Other    
Segment Information    
Share-based compensation   52
Depreciation and amortization   83
Net loss (2) 8,045
Operating segments    
Segment Information    
Revenue 37,758 42,374
Operating segments | Cannabis    
Segment Information    
Revenue 10,389 12,961
Operating segments | Accessories    
Segment Information    
Revenue 27,369 29,413
Inter-segment revenue    
Segment Information    
Revenue (254) (110)
Inter-segment revenue | Accessories    
Segment Information    
Revenue $ (254) $ (110)